Why is Mangalam Drugs falling/rising?

As of 12-Sep, Mangalam Drugs and Organics Ltd is experiencing a decline in its stock price, currently at Rs 75.00, reflecting a decrease of Rs 1.94 or 2.52%. Today's performance indicates that the stock has underperformed its sector by 2.81%, with an intraday low of Rs 74, marking a drop of 3.82%. The stock is trading below its moving averages across various time frames, including 5-day, 20-day, 50-day, 100-day, and 200-day averages. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 24.76% compared to the 5-day average. Over the past year, the stock has generated a return of -41.93%, which is considerably worse than the benchmark's performance.
In the broader market context, the stock's short-term return of -4.02% over the past week contrasts sharply with the Sensex, which has gained 1.48%. The company's financial health is concerning, as it has reported operating losses and a weak ability to service its debt, reflected in a poor EBIT to Interest ratio of 1.73. Furthermore, the company's net sales have declined by 21.48%, and it has posted negative results for the last two consecutive quarters. Despite having a relatively attractive valuation compared to peers, the significant drop in profits and consistent underperformance against the benchmark over the last three years contribute to the stock's current downward trajectory.